The 4 analysts offering 12-month price forecasts for Conmed Corp have a median target of 95.00, with a high estimate of 100.00 and a low estimate of 92.00. The median estimate represents a +20.79% increase from the last price of 78.65.
The current consensus among 6 polled investment analysts is to Buy stock in Conmed Corp. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.26
Reporting Date Oct 29
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.